Researchers from Monash University discover that the anti-parasite ivermectin could kill COVVI-19 cells in two days
At a time when a vaccine race has been launched to find a remedy for COVID-19, researchers from Monash University in Australia, discover that a drug used to treat lice can kill COVVI-19 cells.
These researchers have discovered that ivermectin, an antiparasitic drug against lice can kill COVVI-19 cells in 48 hours in the laboratory. They decided to move towards the tests on man.
According to the study led by Monash University, a single dose of the Ivermectin medication could stop the coronavirus to develop in cell culture.
“We have found that even a single dose could mainly eliminate all the genetic material from the virus in 48 hours with a really significant reduction,” said Dr. Kylie Wagstaff of the Monash Biomedicine Discovery Institute on Friday, April 3, 2020, reported the Daily Mail.
Although we do not yet know how the ivermectin acts on the virus, the drug probably prevents it from multiplying and the next step is for researchers to determine the correct human dosage, to ensure that the level used in vitro is safe for humans.
Ivermectin is an anti-parasitic drug approved by the FDA which has also proved to be effective in vitro against viruses, including HIV, dengue and flu.
